XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 104 filers reported holding XENON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,388 | -19.2% | 2,324 | -8.9% | 0.05% | -17.2% |
| Q2 2023 | $98,252 | +5.2% | 2,552 | -2.2% | 0.06% | +13.7% |
| Q1 2023 | $93,412 | -34.5% | 2,610 | -27.8% | 0.05% | -31.1% |
| Q4 2022 | $142,579 | +7.2% | 3,616 | -1.6% | 0.07% | +39.6% |
| Q3 2022 | $133,000 | +19.8% | 3,673 | +0.8% | 0.05% | +29.3% |
| Q2 2022 | $111,000 | -40.3% | 3,643 | -40.1% | 0.04% | -50.6% |
| Q1 2022 | $186,000 | -7.5% | 6,078 | -5.6% | 0.08% | +9.2% |
| Q4 2021 | $201,000 | +14.2% | 6,439 | -44.0% | 0.08% | -1.3% |
| Q3 2021 | $176,000 | -21.8% | 11,494 | -4.9% | 0.08% | -17.2% |
| Q2 2021 | $225,000 | -49.3% | 12,091 | -51.3% | 0.09% | -50.5% |
| Q1 2021 | $444,000 | +18.4% | 24,819 | +1.8% | 0.19% | +20.5% |
| Q4 2020 | $375,000 | +32.0% | 24,381 | -5.0% | 0.16% | +4.7% |
| Q3 2020 | $284,000 | -22.4% | 25,673 | -12.0% | 0.15% | -13.9% |
| Q2 2020 | $366,000 | – | 29,170 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |